SCHEMBL6927366

SCHEMBL6927366

CC(C)c1cn(CCN2CCOCC2)c2ncnc(N)c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 3/20 0.45
METTL3 Q86U44 1/20 0.39
SRC P12931 2/20 0.39
MET P08581 1/20 0.39
AXL P30530 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
PIK3CD O00329 1/20 0.38
PIK3CA P42336 1/20 0.38
PIK3CB P42338 1/20 0.38
TLR7 Q9NYK1 1/20 0.37
YES1 P07947 1/20 0.37
FGR P09769 1/20 0.37
KDM4E B2RXH2 2/20 0.37
USP2 O75604 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10261380 0.84 FLT3 (0.47) FLT3METTL3SRCMETAXL
SCHEMBL870030 0.81 METTL3 (0.52) FLT3METTL3METAXLMEN1
SCHEMBL10198695 0.79 SRC (0.49) FLT3SRCKMT2APIK3CDPIK3CA
SCHEMBL20810624 0.77 ADORA2A (0.47) FLT3SRCPIK3CDPIK3CAPIK3CB
SCHEMBL10198694 0.77 SRC (0.42) FLT3SRCMETAXLPIK3CD
SCHEMBL20351665 0.76 FLT3 (0.58) FLT3SRCMETAXLMEN1
SCHEMBL6927086 0.74 SRC (0.42) FLT3SRCPIK3CDPIK3CAPIK3CB
SCHEMBL6928045 0.73 SRC (0.46) METTL3SRCPIK3CDPIK3CAPIK3CB
SCHEMBL30582556 0.72 ADORA2A (0.43) SRCPIK3CDPIK3CAPIK3CBLCK
SCHEMBL6925128 0.72 ADORA2A (0.43) SRCPIK3CDPIK3CAPIK3CBLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2549868-B1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2015-01-07 EP disclosed
US-20130018038-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2013-01-17 US disclosed
US-20120077828-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2012-03-29 US disclosed
WO-2011119663-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2011-09-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130018038-A1 CHEMICAL COMPOUNDS BRCA1, IRS1, IGF1R FLT3 2923/4885METTL3 4319/4885SRC 2497/4885
US-20120077828-A1 CHEMICAL COMPOUNDS BRCA1, IRS1, IGF1R FLT3 2923/4885METTL3 4319/4885SRC 2497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.